Uncovering Answers to Protect Patients' Health
Boehringer Ingelheim has a large and experienced global team managing and conducting clinical trials in many indications. During the past decade from 2005 to 2014, Boehringer Ingelheim conducted or sponsored 1,414 studies with approximately one million patients on 115 substances in 95 countries.
-
Estudos clínicos
In compliance with our Policy on Transparency and Publication of Clinical Study Data, Boehringer Ingelheim is committed to disclosing all study results independent of outcome. Responsible sharing of de-identified clinical study data and redacted clinical documents are reported.